Huisheng Biopharmaceutical Funding: $70M Raised, Series A
Huisheng Biopharmaceutical is based in Zhangjiawan, Beijing, China. It has raised $70M in total funding. Latest round: Series A.
Huisheng Biopharmaceutical funding overview
Huisheng Biopharmaceutical is based in Zhangjiawan, Beijing, China. Huisheng Biopharmaceutical has raised $70M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in September 2022. The round record for Huisheng Biopharmaceutical runs through 2022; nothing later has been disclosed. Investors on record include China Life Private Equity Investment, Tianjin Grand Flight Yongxuan, Tianjin Grand Flight Jimao, Ginkgo Capital. 4 distinct backers are named across the disclosed rounds.
Huisheng Biopharmaceutical at a glance
Total raised
$70M
Latest round
Series A
Latest round date
September 2022
Headquarters
Zhangjiawan, Beijing, China
Notable investors
China Life Private Equity Investment, Tianjin Grand Flight Yongxuan, Tianjin Grand Flight Jimao, Ginkgo Capital
Frequently asked about Huisheng Biopharmaceutical funding
How much has Huisheng Biopharmaceutical raised?
Huisheng Biopharmaceutical has raised $70M in total disclosed funding across the rounds on record.
Who has invested in Huisheng Biopharmaceutical?
China Life Private Equity Investment, Tianjin Grand Flight Yongxuan, Tianjin Grand Flight Jimao, Ginkgo Capital are named among the investors backing Huisheng Biopharmaceutical.
What was the latest Huisheng Biopharmaceutical funding round?
The most recent disclosed round is a Series A, announced in September 2022.
Where is Huisheng Biopharmaceutical based?
Huisheng Biopharmaceutical is based in Zhangjiawan, Beijing, China.
When did Huisheng Biopharmaceutical last raise?
The last disclosed Huisheng Biopharmaceutical round closed in September 2022 at Series A.
Huisheng Biopharmaceutical totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Zhangjiawan below to benchmark round size and investor mix.
Companies related to Huisheng Biopharmaceutical (33)
